References

1. Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Zhou AY, et al. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon. Cancer epidemiology, biomarkers & prevention. 2020;29(2):359–67. https://doi.org/10.1158/1055-9965.EPI-19-0506.
   
2. Akbari M, Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, et al. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clinical genetics. Akbari MR, Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, Zhang S, Narod SA, Hurley J. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. 2014;85(1):64–7.https://doi.org/10.1111/cge.12132.
   
3. Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. International journal of cancer. 2012;131(5):1114–23.https://doi.org/10.1002/ijc.27326.
   
4. Pal T, Bonner D, Cragun D, Monteiro AN., Phelan C, Servais L, et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. 2015;121(23):4173–80. https://doi.org/10.1002/cncr.29645.
   
5. George SH, Donenberg T, Alexis C, DeGennaro V, Dyer H, Yin S, Ali J, Butler R, Chin SN, Curling D, Lowe D. Gene sequencing for pathogenic variants among adults with breast and ovarian cancer in the caribbean. JAMA network open. 2021 Mar 1;4(3):e210307-. doi:10.1001/jamanetworkopen.2021.0307.
   
6. Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, Ademola A, Falusi AG, Adebamowo CA, Oluwasola AO, Adeoye A. Inherited Breast Cancer in Nigerian Women. Journal of clinical oncology. 2018;36(28):2820–5. https://doi.org/10.1200/jco.2018.78.3977.
   
7. Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population‐based study. Cancer medicine (Malden, MA). 2017;6(7):1787–98. https://doi.org/10.1002/cam4.1120.
   
8. McCarthy AM, Keller BM, Pantalone LM, Hsieh MK, Synnestvedt M, Conant EF, Armstrong K, Kontos D. Racial Differences in Quantitative Measures of Area and Volumetric Breast Density. JNCI: Journal of the National Cancer Institute. 2016;108(10):djw104–. https://doi.org/10.1093/jnci/djw104.
   
9. del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, et al. Mammographic Breast Density and Race. American journal of roentgenology (1976). 2007;188(4):1147–50. https://doi.org/10.2214/ajr.06.0619.
   
10. Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013. Breast cancer research and treatment. 2018;169(3):595–606. https://doi.org/10.1007/s10549-018-4699-9.
    
11. Prakash O, Hossain F, Danos D, Lassak A, Scribner R, Miele L. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors. Frontiers in public health. 2020;8:576964–576964. https://doi.org/10.3389/fpubh.2020.576964.
    
12. Eberle CE, Sandler DP, Taylor KW, White AJ. Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women. International journal of cancer. 2020;147(2):383–91.https://doi.org/10.1002/ijc.32738.
    
13. McKenzie, K. Toronto’s Black community faces far greater risk of having serious mental health problems. [Internet]. Toronto Star. 2020 Jan 27. Available from:https://www.thestar.com/opinion/contributors/2020/01/27/torontos-black-community-faces-far-greater-risk-of-having-serious-mental-health-problems.html
    
14. Harris SS. Vitamin D and African Americans. The Journal of nutrition. 2006;136(4):1126–9. https://doi.org/10.1093/jn/136.4.1126.
    
15. Aleshire, M. E., Adegboyega, A., Escontrías, O. A., Edward, J., & Hatcher, J. (2021). Access to Care as a Barrier to Mammography for Black Women. Policy, Politics, & Nursing Practice, 22(1), 28-40. https://doi.org/10.1177/1527154420965537
    
16. Davis, C., Cadet, T. J., Moore, M., & Darby, K. (2017). A comparison of compliance and noncompliance in breast cancer screening among African American women. Health & social work, 42(3), 159-166.
    
17. Kim, S. J., Glassgow, A. E., Watson, K. S., Molina, Y., & Calhoun, E. A. (2018). Gendered and racialized social expectations, barriers, and delayed breast cancer diagnosis. Cancer, 124(22), 4350-4357. https://doi.org/10.1002/cncr.31636
    
18. Miles, R. C. (2020). Closing the Gap: Disparities in Breast Cancer Mortality among African American Women. Radiology: Imaging Cancer, 2(5). doi:10.1148/rycan.2020200124
    
19. Vahabi, Lofters, A., Kim, E., Wong, J. P.-H., Ellison, L., Graves, E., & Glazier, R. H. (2017). Breast cancer screening utilization among women from Muslim majority countries in Ontario, Canada. Preventive Medicine, 105, 176–183. https://doi.org/10.1016/j.ypmed.2017.09.008.
    
20. Nnorom, O., Sappong-Kumankumah, A., Olaiya, O. R., Burnett, M., Akor, N., Shi, N., … & Lofters, A. (2021). Afrocentric screening program for breast, colorectal, and cervical cancer among immigrant patients in Ontario. Canadian Family Physician, 67(11), 843-849.doi: https://doi.org/10.46747/cfp.6711843
    
21. American Cancer Society. 2022. Triple negative breast cancer. https://www.cancer.org/cancer/breast-cancer/about/types-of-breast-cancer/triple-negative.html.
    
22. Sung, H., DeSantis, C. E., Fedewa, S. A., Kantelhardt, E. J., & Jemal, A. (2019). Breast cancer subtypes among Eastern‐African–born black women and other black women in the United States. Cancer, 125(19), 3401-3411. https://doi.org/10.1002/cncr.32293
    
23. Cho, B., Han, Y., Lian, M., Colditz, G. A., Weber, J. D., Ma, C., & Liu, Y. (2021). Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer. JAMA oncology. doi:10.1001/jamaoncol.2021.1254
    
24. Lofters, A. K., McBride, M. L., Li, D., Whitehead, M., Moineddin, R., Jiang, L., … & Groome, P. A. (2019). Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study. BMC cancer, 19(1), 1-11.
    
25. Reeder‐Hayes, K. E., Mayer, S. E., Olshan, A. F., Wheeler, S. B., Carey, L. A., Tse, C. K., … & Troester, M. A. (2019). Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study. Cancer, 125(22), 3985-3992. https://doi.org/10.1002/cncr.32378
    
26. Walsh, R. L., Lofters, A., Moineddin, R., Krzyzanowska, M., & Grunfeld, E. (2021). Primary Care Continuity and Wait Times to Receiving Breast Cancer Chemotherapy: A Population-Based Retrospective Cohort Study Using CanIMPACT Data. Current Oncology, 28(6), 4786-4804.https://doi.org/10.3390/curroncol28060405
    
27. Jones, C. E., Maben, J., Lucas, G., Davies, E. A., Jack, R. H., & Ream, E. (2015). Barriers to early diagnosis of symptomatic breast cancer: A qualitative study of Black African, Black Caribbean and White British women living in the UK. Retrieved December 2, 2021, from https://bmjopen.bmj.com/content/5/3/e006944